Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer

Ovarian cancer is the deadliest of all gynecologic cancers. Despite success with initial chemotherapy, the majority of patients relapse with an incurable disease. Development of chemotherapy resistance is a major factor for poor long-term survival in ovarian cancer. The biological effects of estroge...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Liu, Jinyou, Viswanadhapalli, Suryavathi, Garcia, Lauren, Zhou, Mei, Nair, Binoj C., Kost, Edward, Tekmal, Rajeshwar Rao, Li, Rong, Rao, Manjeet K., Curiel, Tyler, Vadlamudi, Ratna K., Sareddy, Gangadhara R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564823/
https://ncbi.nlm.nih.gov/pubmed/28654894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18442
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak